These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 215929)

  • 1. In vitro release of ACTH from dispersed rat pars intermedia cells. III. Multiple forms of ACTH biological activity.
    Kraicer J; Elliot NL; Zimmerman AE
    Neuroendocrinology; 1978; 27(1-2):86-96. PubMed ID: 215929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro release of ACTH from dispersed rat pars intermedia cells. I. Effect of secretagogues.
    Kraicer J; Morris AR
    Neuroendocrinology; 1976; 20(1):79-96. PubMed ID: 180446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release of ACTH from dispersed rat pars intermedia cells. II. Effect of neurotransmitter substances.
    Kraicer J; Morris AR
    Neuroendocrinology; 1976; 21(2):175-92. PubMed ID: 13323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-releasing hormone does not alter the release of melanocyte-stimulating hormone or adrenocorticotropic hormone from the rat pars intermedia.
    Kraicer J
    Neuroendocrinology; 1977; 24(3-4):226-31. PubMed ID: 204881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and secretion of proopiomelanocortin peptides from isolated perifused dog pituitary pars intermedia cells.
    Kemppainen RJ; Zerbe CA; Sartin JL
    Endocrinology; 1989 May; 124(5):2208-17. PubMed ID: 2539971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro regulation of ACTH release from neurointermediate lobe of rat hypophysis. I. Effect of crude hypothalamic extracts.
    Briaud B; Koch B; Lutz-Bucher B; Mialhe C
    Neuroendocrinology; 1978; 25(1):47-63. PubMed ID: 206849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of pro-opiomelanocortin-derived peptides from the pars intermedia and pars distalis of the rat pituitary: effect of corticotrophin-releasing factor and somatostatin.
    Kraicer J; Gajewski TC; Moor BC
    Neuroendocrinology; 1985 Nov; 41(5):363-73. PubMed ID: 2865690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive and simple in vitro assay for corticotropin-releasing substances utilizing ACTH release from cultured anterior pituitary cells.
    Takebe K; Yasuda N; Greer MA
    Endocrinology; 1975 Nov; 97(5):1248-55. PubMed ID: 171148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct action of serotonin on prolactin, growth hormone, corticotropin and luteinizing hormone release in cocultures of anterior and posterior pituitary lobes: autocrine and/or paracrine action of vasoactive intestinal peptide.
    Balsa JA; Sánchez-Franco F; Pazos F; Lara JI; Lorenzo MJ; Maldonado G; Cacicedo L
    Neuroendocrinology; 1998 Nov; 68(5):326-33. PubMed ID: 9822800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness of adenohypophysial corticotrophs to hypothalamic (SME) extract remains unchanged in rats with hypothalamic lesions inhibiting CRF release.
    Stark E; Kárteszi M; Makara GB
    Neuroendocrinology; 1983 May; 36(5):330-4. PubMed ID: 6304553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of bioactive corticotropin release from the neuro-intermediate lobe of the rat pituitary in vitro.
    Fischer JL; Moriarty CM
    Endocrinology; 1977 Apr; 100(4):1047-54. PubMed ID: 189989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of ACTH and MSH release from the pars intermedia: in vitro studies.
    Kraicer J
    Front Horm Res; 1977; 4():200-7. PubMed ID: 207597
    [No Abstract]   [Full Text] [Related]  

  • 13. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
    Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
    J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars intermedia ACTH and MSH content: effect of adrenalectomy, gonadectomy and a neurotropic (noise) stress.
    Kraicer J; Beraud G; Lywood DW
    Neuroendocrinology; 1977; 23(6):352-67. PubMed ID: 201881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro studies on corticotropin releasing activity of vasopressin and hypothalamic median eminence extract.
    Lutz-Bucher B; Koch B; Mialhe C
    Neuroendocrinology; 1977; 23(3):181-92. PubMed ID: 197442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of pro-opiocortin peptides from isolated perfused rat pars intermedia cells.
    Jackson S; Lowry PJ
    Neuroendocrinology; 1983 Oct; 37(4):248-57. PubMed ID: 6138722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of monoamines on ACTH secretion by dispersed perfused cells from the adenohypophysis of barcino chico duck (Anas flavirostris)].
    Castro MG; Morano MI; Estivariz FE; Iturriza FC
    Acta Physiol Pharmacol Latinoam; 1986; 36(4):347-57. PubMed ID: 2886008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of several in vitro systems on the potencies of putative adrenocorticotropin secretagogues on rat anterior pituitary cells.
    Watanabe T; Orth DN
    Endocrinology; 1988 May; 122(5):2299-308. PubMed ID: 2834188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTH-like bioactivity and immunoactivity in fetal lamb pituitaries at 0.65 and 0.95 gestation.
    Fora MA; Valego NK; Lively MO; Castro MI; Rose JC
    Reprod Fertil Dev; 1996; 8(1):195-201. PubMed ID: 8713741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin-induced ACTH release from rat pituitary tissue in vitro.
    Okajima T; Hertting G
    Neuroendocrinology; 1986; 43(3):336-9. PubMed ID: 2426624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.